Medindia

REMfresh®, The First And Only Drug-Free Sleep Product Of Its Type, Shows Excellent Safety And Tolerability In REMSU24, A Comprehensive Post-Marketing Surveillance Study

REMSU24 captured and analyzed serious and non-serious adverse event reports for REMfresh over a 24-month period from March 9, 2017 to March 9, 2019. "The findings from REMSU24 are consistent with the ...
Mena FN

REMfresh Continuous Release Melatonin Exceeds Target Sleep Maintenance Threshold for 6.7 Hours

(MENAFN- ForPressRelease) 7 Clinical data presented today highlight findings on non-prescription sleep product, REMfresh, a continuous release and absorption melatonin (CRA-melatonin). REMfresh is ...
Medindia

First-Ever Study Of 7-Hour, Drug-Free Continuous Release And Absorption Melatonin (Cra-melatonin™) REMFresh®, Published In Primary Care Companion For CNS Disorders Journal

MEMPHIS, Tenn. and BOCA RATON, Fla., Aug. 2, 2019 /PRNewswire/ -- Physician's Seal, LLC, today announced that Primary Care Companion for CNS Disorders, a peer-reviewed primary care medical journal, ...
Mena FN

Physicians Seal, LLC Announces Data Analysis Plans for Ongoing Patient

(MENAFN- ForPressRelease) Physicians Seal, LLC, innovators of REMfresh (CRA-melatonin), a clinically studied, drug-free, nonprescription sleep brand, today announced the data analysis plans for two ...
Nasdaq

Nestlé Health Science To Buy IM HealthScience; Financial Terms Not Disclosed

(RTTNews) - Nestlé Health Science, a unit of Swiss food major Nestlé (NSRGY.PK, NSTR.L), announced Tuesday that it has agreed to acquire the business of privately held IM HealthScience with its brands ...